| |
| Issue |
Title |
| |
| No 23 (2024) |
Association of genes CSK, MTHFR, АСЕ, ADRA2B, TCF7L2 with metabolic syndrome in indigenous and non-indigenous young residents of Western Siberia |
Abstract
PDF (Rus)
|
|
E. V. Korneeva, M. I. Voevoda, V. N. Maksimov, S. E. Semaev |
| |
| No 23 (2024) |
Telemedicine-assisted cardiac rehabilitation: A controlled cohort clinical trial |
Abstract
PDF (Rus)
|
|
I. E. Mishina, E. V. Berezina, K. A. Blinova, A. S. Parfenov, O. V. Lebedeva, O. V. Khoroshilova, A. A. Gudukhin, M. V. Zhaburina, Yu. V. Dovgaluk |
| |
| No 23 (2024) |
Thrombocytopenia in COVID-19 patients: The role of fondaparinux and succinates in improving outcomes (exchange of experience) |
Abstract
PDF (Rus)
|
|
N. Yu. Semigolovskii, V. A. Ratnikov, I. S. Simutis, A. V. Svetlikov, L. G. Ermolaeva, D. S. Salygina, M. S. Danilov, S. N. Semigolovskii, A. A. Gorokhov, M. S. Mazurenko |
| |
| No 23 (2024) |
Cardioinhibitory variant of syncope induced during a long-term passive orthostatic test |
Abstract
PDF (Rus)
|
|
F. Kh. Orakova, A. B. Khadzugov, I. K. Tkhabisimova, М. М. Tkhabisimova, R. Kh. Medalieva, D. Z. Mizova, M. M. Azikov, D. M. Afaunova, A. R. Khanieva, F. T. Akezheva, A. T. Mollaeva, L. V. Lukozheva |
| |
| No 13 (2024) |
Are there any benefits from prescribing a cardiac cytoprotector to enhance the quality of life in patients with coronary heart disease and chronic heart failure? |
Abstract
PDF (Rus)
|
|
M. Е. Statsenko, S. V. Turkina, Yu. Е. Lopushkova |
| |
| No 13 (2024) |
The level of factor X coagulation and the risk of adverse reactions during treatment with rivaroxaban and apixaban in patients with non-valvular atrial fibrillation |
Abstract
PDF (Rus)
|
|
E. K. Kochetkova, A. A. Astapovskii, N. P. Kulagina, V. N. Drozdov, G. G. Melkonyan, S. Yu. Serebrova, E. V. Shikh |
| |
| No 13 (2024) |
Antihypertensive therapy in pregnant women with chronic hypertension |
Abstract
PDF (Rus)
|
|
V. S. Chulkov, E. S. Nikolenko, V. D. Nikolaeva, E. E. Minina, V. S. Chulkov |
| |
| No 13 (2024) |
Metabolic therapy in the treatment of cardiovascular diseases |
Abstract
PDF (Rus)
|
|
V. S. Kopylova, S. E. Boronovskiy, L. P. Sokolova, E. V. Mashkovtseva, Ya. R. Nartsissov |
| |
| No 23 (2023) |
A clinical case of viral myocarditis associated with sars-cov-2 in a health worker |
Abstract
PDF (Rus)
|
|
S. A. Babanov, T. A. Azovskova, N. E. Lavrentyeva, R. A. Baraeva |
| |
| No 23 (2023) |
Clinical features and treatment options for obstructive hypertrophic cardiomyopathy in women |
Abstract
PDF (Rus)
|
|
V. A. Mosina, I. V. Demko, N. V. Gordeeva, L. I. Pelinovskaya, Ya. I. Verigo, O. B. Mashtakova |
| |
| No 23 (2023) |
Cardioprotection with levocarnitine intracoronary administration during percutaneous coronary interventions |
Abstract
PDF (Rus)
|
|
N. Yu. Semigolovskii, M. F. Ballyuzek, S. O. Mazurenko, A. B. Guslev, A. V. Kozaev, E. M. Nikolskaya, I. G. Semenova |
| |
| No 23 (2023) |
Current ideas about the role of ranolazine in patients’ treatment with angina pectoris |
Abstract
PDF (Rus)
|
|
S. R. Gilyarevskiy, O. N. Tkacheva |
| |
| No 13 (2023) |
Features of the treatment of arterial hypertension in elderly patients |
Abstract
PDF (Rus)
|
|
M. V. Leonova |
| |
| No 13 (2023) |
Clinical and pharmacological approaches to personalization of the prescription of oral anticoagulants: clinical cases |
Abstract
PDF (Rus)
|
|
L. V. Fedina, I. N. Sychev, T. D. Rastvorova, K. B. Mirzaev, D. A. Sychev |
| |
| No 6 (2023) |
Experience in the treatment of patients with pulmonary embolism using apixaban and ultrasound inhalations of unfractionated heparin |
Abstract
PDF (Rus)
|
|
N. Yu. Semigolovskii, S. O. Mazurenko, I. S. Simutis, L. G. Ermolaeva, S. N. Semigolovskii |
| |
| No 6 (2023) |
Rehabilitation treatment of patients with stable angina with long-term complex use of physiotherapy methods |
Abstract
PDF (Rus)
|
|
E. V. Kasparov, A. N. Razumov, S. V. Klemenkov, A. S. Klemenkov, I. V. Kubushko |
| |
| No 6 (2023) |
Comparative study of myocardial damage in hantavirus and new coronavirus infection |
Abstract
PDF (Rus)
|
|
G. A. Galieva, G. Kh. Mirsaeva, R. M. Fazlyeva, E. R. Kamaeva, O. L. Andrianova, D. I. Masalimova, A. Kh. Islamgulov, V. V. Nikulina, A. R. Imaeva |
| |
| No 6 (2023) |
A clinical case of successful thrombolysis in pulmonary embolism during pregnancy |
Abstract
PDF (Rus)
|
|
A. V. Andreeva, A. V. Danilov, L. S. Devyatova, K. A. Moseichuk, E. V. Filippov |
| |
| No 6 (2023) |
Opportunistic screening for familial hypercholesterolemia based on observational registries data analysis |
Abstract
PDF (Rus)
|
|
O. V. Gaisenok |
| |
| No 6 (2022) |
New opportunities in the treatment of asthenic symptoms after a new coronavirus infection |
Abstract
PDF (Rus)
|
|
V. N. Shishkova, A. I. Martynov |
| |
| No 6 (2022) |
New treatment options for a patient with chronic heart failure and chronic obstructive pulmonary disease |
Abstract
PDF (Rus)
|
|
M. E. Statsenko, S. V. Turkina, Yu. E. Lopushkova, M. A. Kosivtsova |
| |
| No 21-2 (2021) |
Comorbid patient with arterial hypertension: difficulties in diagnosis and treatment |
Abstract
PDF (Rus)
|
|
E. I. Polozova, V. V. Skvortsov, A. A. Seskina, A. A. Mironov, A. R. Starova, R. Yu. Bangarov |
| |
| No 21-2 (2021) |
The role of non-drug methods of increasing adherence to the treatment of patients with arterial hypertension in a polyclinic |
Abstract
PDF (Rus)
|
|
S. S. Simenyura, Zh. M. Sizova |
| |
| No 21 (2020) |
Proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors in the treatment of dyslipidemia |
Abstract
PDF (Rus)
|
|
A. A. Shikaleva, M. L. Maximov, N. M. Kiseleva |
| |
| No 21 (2020) |
The relationship of risk factors and heart remodeling in patients with metabolic syndrome and arterial hypertension |
Abstract
PDF (Rus)
|
|
E. L. Polozova, E. V. Puzanova, A. A. Seskina, N. S. Nefedov |
| |
| No 21 (2020) |
Drug-induced arrhythmias |
Abstract
PDF (Rus)
|
|
M. V. Leonova |
| |
| No 4 (2020) |
Efficiency (advantages) of ramipril in arterial hypertension and diabetes mellitus from the point of view of evidence-based medicine |
Abstract
PDF (Rus)
|
|
M. V. Leonova |
| |
| No 4 (2020) |
European Consensus on use of diuretics in chronic heart failure 2019 |
Abstract
PDF (Rus)
|
|
M. V. Leonova |
| |
| No 4 (2020) |
Relationship of type 2 diabetes mellitus and cardiovascular pathology: significance of glycemic control on the way to solving the problem |
Abstract
PDF (Rus)
|
|
G. N. Gorokhovskaya, V. L. Yun, A. I. Martynov, E. Yu. Maychuk, Yu. A. Vasyuk, M. M. Petina, S. V. Moiseyenko |
| |
| No 4 (2020) |
New 2019 ESC Guidelines for Diagnosis and Management of Chronic Coronary Syndromes (review) |
Abstract
PDF (Rus)
|
|
V. P. Lupanov |
| |
| No 4 (2020) |
Condition of microcirculation according to a thermovision research at young men of military age with a neurocirculatory asthenia |
Abstract
PDF (Rus)
|
|
V. S. Ivanov, S. N. Ivanov |
| |
| No 4 (2020) |
Primary prevention of cardiovascular diseases in diabetes mellitus: 2020 strategy |
Abstract
PDF (Rus)
|
|
V. I. Novikov, K. Yu. Novikov |
| |
| No 21 (2019) |
Efficacy of a fixed-dose combination (amlodipine/losartan) in the treatment of a patient with arterial hypertension, dyslipidemia and obesity |
Abstract
PDF (Rus)
|
|
V. P. Mikhin |
| |
| No 21 (2019) |
Drug adjustment of modified risk factors as one of the leading strategies for managing patients with cardiovascular diseases |
Abstract
PDF (Rus)
|
|
S. K. Zyryanov, E. A. Baybulatova |
| |
| No 21 (2019) |
Laboratory bleeding predictors in elderly patients with atrial fibrillation taking direct oral anticoagulants |
Abstract
PDF (Rus)
|
|
M. A. Gabitova, P. M. Krupenin, A. A. Sokolova, D. A. Napalkov, V. V. Fomin |
| |
| No 21 (2019) |
Prospects of rivaroxaban application in treatment of patients with chronic ischemic heart disease |
Abstract
PDF (Rus)
|
|
N. B. Perepech |
| |
| No 21 (2019) |
Vascular age concept: role in assessing risk and choosing therapy |
Abstract
PDF (Rus)
|
|
S. R. Gilyarevsky, M. V. Golshmid, N. G. Bendeliani, I. M. Kuzmina, G. Y. Zaharova, I. I. Sinitcina |
| |
| No 21 (2019) |
Modern aspects of surgical treatment of patients with atrial fibrillation. Development of uniform criteria for selecting patients for radiofrequency ablation |
Abstract
PDF (Rus)
|
|
I. A. Libov, I. M. Mayorov, L. P. Porunov |
| |
| No 21 (2019) |
Safety of dabigatran in patients with atrial fibrillation and chronic kidney disease: pharmacokinetic and pharmacogenetic aspects |
Abstract
PDF (Rus)
|
|
A. I. Skripka, P. O. Bochkov, K. A. Akmalova, R. V. Shevchenko, P. M. Krupenin, V. V. Kogay, A. I. Listratov, A. S. Krainyaya, D. A. Napalkov, O. S. Gurinovich, A. A. Sokolova, V. V. Fomin, D. A. Sychev |
| |
| No 12 (2019) |
Prevalence of endothelial dysfunction and dyslipidemia in patients with chronic rheumatic heart disease |
Abstract
PDF (Rus)
|
|
V. S. Petrov |
| |
| No 6 (2019) |
Heart failure. The current state of the problem: achievements, frustrations, hopes and prospects |
Abstract
PDF (Rus)
|
|
E. F. Pavlysh, V. N. Khirmanov, A. V. Pavlysh |
| |
| No 21 (2018) |
Possibilities of nicorandil for coronary insufficiency correction in patients with ischemic heart disease and diabetes mellitus type 2 |
Abstract
PDF (Rus)
|
|
Zh. M. Sizova, V. L. Zakharova, N. V. Kozlova |
| |
| No 21 (2018) |
Therapeutic potential of apixaban at different stages of management of patients with pulmonary thromboembolism |
Abstract
PDF (Rus)
|
|
O. V. Averkov, V. I. Vechorko, O. A. Shapsigova |
| |
| No 21 (2018) |
Thrombocytopenia and prospective endovascular intervention in a patient with coronary artery disease |
Abstract
PDF (Rus)
|
|
A. B. Sumarokov, L. I. Buryachkovskaya, N. V. Lomakin |
| |
| No 21 (2018) |
Differentiated approach to the use of optimal medical therapy in patients with various clinical forms of stable ischemic heart disease |
Abstract
PDF (Rus)
|
|
I. I. Shaposhnik, V. I. Karnot, T. M. Karandasova, O. F. Bannikova, O. G. Bocharova, L. V. Belolipetskaya, E. V. Lebedev, A. O. Salashenko |
| |
| No 21 (2018) |
Aspirin and statins: possibilities for joint improvement of prognosis in cardiovascular disease |
Abstract
PDF (Rus)
|
|
К. G. Pereverzeva, S. S. Yakushin |
| |
| No 21 (2018) |
The place of ramipril in modern guidelines for the management of patients with cardiovascular diseases |
Abstract
PDF (Rus)
|
|
E. E. Averin, A. E. Nikitin, I. G. Nikitin, A. V. Sozykin |
| |
| No 12 (2018) |
Topical issues of beta-blockers use in various clinical situations |
Abstract
PDF (Rus)
|
|
D. V. Nebieridze |
| |
| No 6 (2018) |
Use of antithrobomic agents in pregnancy and lactation: from the viewpoint of the cardiologist/rheumatologist (literature review) |
Abstract
PDF (Rus)
|
|
A. E. Bagry, O. A. Prikolota, E. V. Schukina, M. V. Khomenko, E. E. Kovyrshina |
| |
| No 6 (2018) |
New data on the use of rosuvastatin and acetylsalicyl acid for the prolongation of human life |
Abstract
PDF (Rus)
|
|
M. V. Ezhov, P. S. Laguta |
| |
| No 20 (2017) |
THROMBOCYTOPENIA IN THE STRUCTURE OF HEMATOLOGICAL DISORDERS IN PATIENTS OF A MULTIPROFILE HOSPITAL AND POSSIBLE WAYS TO OPTIMIZE ITS EVALUATION |
Abstract
PDF (Rus)
|
|
S. Yu. Semigolovskii, T. V. Vavilova, V. A. Kashchenko, S. N. Semigolovskii, A. A. Sapegin |
| |
| No 20 (2017) |
METABOLIC TANDEM TARGETS: NON-ALCOHOLIC FATTY LIVER DISEASE AND TYPE 2 DIABETES MELLITUS |
Abstract
PDF (Rus)
|
|
L. A. Zvenigorodskaya, A. M. Mkrtumyan, M. V. Shinkin, T. V. Nilova, A. V. Petrakov |
| |
| No 20 (2017) |
TREATMENT OF CHRONIC HEART FAILURE WITH PRESERVED LEFT VENTRICULAR EJECTION FRACTION IN PATIENTS WITH HYPERTENSION DISEASE: POTENTIAL THERAPEUTIC ROLE OF STATINES |
Abstract
PDF (Rus)
|
|
S. G. Kanorsky, A. F. Sereda |
| |
| No 20 (2017) |
INDIVIDUAL ANTIPLATELET THERAPY IN PATIENTS WITH ATHEROSCLEROSIS OF LOWER EXTREMITIES: MYTH OR REALITY? |
Abstract
PDF (Rus)
|
|
O. V. Sirotkina, N. A. Surint, A. A. Topanova, T. V. Vavilova |
| |
| No 20 (2017) |
MONO- OR COMBINED ANTIHYPERTENSIVE THERAPY IN WOMEN WITH ARTERIAL HYPERTENSION AND MODERATE RISK OF CARDIOVASCULAR DISEASES: WHAT’S BETTER? |
Abstract
PDF (Rus)
|
|
R. I. Stryuk, Y. V. Brytkova, O. V. Tatarinova |
| |
| No 20 (2017) |
ANTIHYPERTENSIVE AND VASOPROTECTIVE EFFECTS OF FOSINOPRILE IN PATIENTS WITH ARTERIAL HYPERTENSION |
Abstract
PDF (Rus)
|
|
N. Yu. Grigorieva, A. N. Kuznetsov, M. E. Koroleva, T. V. Koroleva, O. E. Vilkova |
| |
| No 5 (2017) |
ASPECTS OF MODERN COMBINATION SPECIFIC THERAPY OF PULMONARY ARTERIAL HYPERTENSION: THE PROS AND CONS |
Abstract
PDF (Rus)
|
|
T. V. Martynyuk, S. N. Nakonechnikov, I. Ye. Chazova |
| |
| No 5 (2017) |
THE EFFICACY OF MELDONIUM IN PATIENTS WITH CHRONIC HEART FAILURE OF ISCHEMIC ETIOLOGY WITH COMORBIDITIES |
Abstract
PDF (Rus)
|
|
M. E. Statsenko, S. V. Turkina, S. V. Fabritskaya, I. A. Tyschenko, L. V. Poletayeva |
| |
| No 11 (2017) |
SAFETY OF DIRECT ORAL ANTICOAGULANTS IN PATIENTS WITH ATRIAL FIBRILLATION: A TWO-YEAR COHORT STUDY |
Abstract
PDF (Rus)
|
|
A. V. Zhilenko, A. A. Sokolova, I. L. Tsarev, D. A. Napalkov |
| |
| No 11 (2017) |
FIXED ETIOPATHOGENETIC COMBINATION OF DRUGS TO TREAT ARTERIAL HYPERTENSION |
Abstract
PDF (Rus)
|
|
M. P. Savenkov, S. N. Ivanov, M. P. Mikhailusova, М. V. Borschevskaya, I. N. Okuneva, L. A. Solomonova, А. M. Savenkova |
| |
| No 17 (2016) |
European recommendations on therapy of dyslipidemias – 2016 Lipid-lowering therapy in patients with acute coronary syndrome and percutaneous coronary interventions |
Abstract
PDF (Rus)
|
|
Y. A. Karpov, O. S. Bulkina |
| |
| No 17 (2016) |
What drugs do hypertension patients take in clinical practice? Structure of antihypertensive drugs in a large siberian region |
Abstract
PDF (Rus)
|
|
Y. I. Grinshtein, M. M. Petrova, V. V. Shabalin, R. R. Ruf, N. V. Topolskaya, A. A. Kosinova, A. Y. Shtrikh |
| |
| No 19 (2016) |
NEW POSSIBILITIES OF TREATMENT OF PATIENTS WITH ISHEMIC HEART DISEASE AND STABLE ANGINA |
Abstract
PDF (Rus)
|
|
A. A. SIMAKOV, M. I. PANINA |
| |
| No 19 (2016) |
KEY PROVISIONS OF THE NEW (2016) EUROPEAN GUIDELINES FOR MANAGEMENT OF DYSLIPIDEMIAS AND COMMENTS |
Abstract
PDF (Rus)
|
|
M. G. BUBNOVA |
| |
| No 19 (2016) |
OPTIMAL CHOICE OF THE DRUG COMBINATION IN ARTERIAL HYPERTENSION THERAPY. FOCUS AT COMBINATION OF ANTIOTENSIN-CONVERTING ENZYME AND CALCIUM ANTAGONIST COMBINATION |
Abstract
PDF (Rus)
|
|
N. A. DJAIANI |
| |
| No 5 (2016) |
Длительное применение апиксабана у 91-летней пациентки с фибрилляцией предсердий, имеющей высокие риски тромбоэмболических и геморрагических осложнений |
Abstract
PDF (Rus)
|
|
, |
| |
| No 4 (2016) |
Effect of statins on LDL cholesterol and lower risk of cardiovascular complications. Which medication to choose? |
Abstract
PDF (Rus)
|
|
N. M. Savina, B. A. Sidorenko |
| |
| No 5 (2016) |
Метаболические эффекты миметика глюкагоноподобного пептида-1 у больных сахарным диабетом 2-го типа в сочетании с кардиоваскулярной патологией |
Abstract
PDF (Rus)
|
|
, , |
| |
| No 4 (2016) |
The place of metoprolol tartrate in the treatment of cardiovascular diseases |
Abstract
PDF (Rus)
|
|
N. V. Romanova, I. V. Zhirov |
| |
| No 5 (2016) |
«Пульс жизни» и ВЦИОМ выяснили, что примерно у трети россиян повышенные риски развития инсульта |
Abstract
PDF (Rus)
|
|
|
| |
| No 4 (2016) |
Riociguat is a novel medication for the treatment of pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension |
Abstract
PDF (Rus)
|
|
N. A. Tsareva, S. N. Avdeev |
| |
| No 5 (2016) |
Тромболизис – чрескожное коронарное вмешательство при остром коронарном синдроме с подъемом сегмента ST: смена акцентов |
Abstract
PDF (Rus)
|
|
, , |
| |
| No 4 (2016) |
Effect of angiotensin II receptor blockers and calcium antagonists on cognition |
Abstract
PDF (Rus)
|
|
O. D. Ostroumova, E. I. Pervichko, N. Y. Galeeva |
| |
| No 5 (2016) |
Клиническая фармакология ацетилсалициловой кислоты и особенности лекарственных форм – ключ к эффективному и безопасному применению для профилактики тромбозов |
Abstract
PDF (Rus)
|
|
, |
| |
| No 5 (2016) |
Эффективность Аторвастатина при лечении дислипидемии у больных с метаболическим синдромом |
Abstract
PDF (Rus)
|
|
, , |
| |
| No 9 (2016) |
APIXABAN – FROM RECOMMENDATIONS TO EVERYDAY PRACTICE |
Abstract
PDF (Rus)
|
|
L. N. ELISEEVA, A. Y. BLEDNOVA, N. N. DENISOVA, E. L. SHUKHARDINA |
| |
| No 9 (2016) |
CURRENT PROSPECTS FOR THE TREATMENT OF DIABETES COMPLICATIONS |
Abstract
PDF (Rus)
|
|
M. Y. OGARKOV, Y. V. KOVALEVA |
| |
| No 10 (2016) |
EPIDEMIOLOGY AND MANAGEMENT OF HEART FAILURE PATIENTS WITH ATRIAL FIBRILLATION |
Abstract
PDF (Rus)
|
|
Y. F. OSMOLOVSKAYA, N. V. ROMANOVA, I. V. ZHIROV, S . N. TERESCHENKO |
| |
| No 10 (2016) |
ANTI-THROMBOCYTIC DRUGS FOR ACUTE CORONARY SYNDROME: DIRECT COMPARISON OF HEMORRHAGIC SAFETY THROMBOCYTE P2Y12-RECEPTOR BLOCKERS TICAGRELOR AND CLOPIDROGEL (BASED ON PLATO STUDY RESULTS |
Abstract
PDF (Rus)
|
|
O. V. AVERKOV |
| |
| No 10 (2016) |
EFFECT OF L-CARNITINE ON OXYDATIVE STRESS AT CARDIOVASCULAR DISEASES |
Abstract
PDF (Rus)
|
|
E. I. ASTASHKIN, M. G. GLEZER |
| |
| No 11 (2015) |
Metoprolol tartrate. Сlinical use |
Abstract
PDF (Rus)
|
|
A. A. Zateischikova |
| |
| No 17 (2015) |
Warfarin and its role in the prevention of thromboembolism in atrial fibrillation (lecture) |
Abstract
PDF (Rus)
|
|
Y. V. Shubik |
| |
| No 17 (2015) |
The selection algorithm for antianginal agents |
Abstract
PDF (Rus)
|
|
A. A. Upnitskiy |
| |
| No 17 (2015) |
Calcium antagonists: from history of creation to modern clinical practice |
Abstract
PDF (Rus)
|
|
A. N. Kuchmin, D. V. Cherkashin |
| |
| No 2 (2015) |
Balance of efficacy and safety in the prevention of stroke in patients with non-valvular atrial fibrillation: potential of apixaban. Questions and answers |
Abstract
PDF (Rus)
|
|
I. S. Yavelov |
| |
| No 2 (2015) |
Hypertension and sensorineural hearing loss: relevance of the problem and the specifics of treatment (focus on Olmesartan) |
Abstract
PDF (Rus)
|
|
A. G. Evdokimova, S. A. Yunko, M. V. Gunchikov |
| |
| No 2 (2015) |
The specifics of using nitrates in the treatment of stable angina |
Abstract
PDF (Rus)
|
|
A. G. Evdokimova, V. V. Evdokimov, A. V. Smetanin, K. I. Tebloyev |
| |
| No 4 (2015) |
In the wake of the latest clinical guidelines - mineralocorticoid receptor antagonists in the treatment of chronic heart failure |
Abstract
PDF (Rus)
|
|
I. V. Zhirov, Y. F. Osmolovskaya, S. N. Tereschenko |
| |
| No 4 (2015) |
Pentoxifylline for intermittent claudication |
Abstract
PDF (Rus)
|
|
N. A. Vaulin |
| |
| No 4 (2015) |
Efficacy of Isoket inhalation in patients with angina pectoris |
Abstract
PDF (Rus)
|
|
A. A. Kirichenko |
| |
| No 11 (2014) |
Антитромботическая терапия при фибрилляции предсердий: новые пероральные антикоагулянты |
Abstract
PDF (Rus)
|
|
|
| |
| No 17 (2014) |
Antihypertensive therapy in obesity |
Abstract
PDF (Rus)
|
|
S. V. Nedogoda, A. S. Salasyuk, I. N. Barykina, V. V. Tsoma, E. V. Chumachek, V. Y. Khripaeva |
| |
| No 17 (2014) |
Комбинированная терапия артериальной гипертензии |
Abstract
PDF (Rus)
|
|
Editorial Article |
| |
| No 17 (2014) |
Current approaches to management of patients with pulmonary hypertension |
Abstract
PDF (Rus)
|
|
S. N. Avdeev |
| |
| No 2 (2014) |
Multimodal prevention of venous thromboembolic complications after total hip and knee joint endoprosthesis |
Abstract
PDF (Rus)
|
|
Y. L. Shevchenko, Y. M. Stoyko, M. N. Zamyatin, A. A. Gritsyuk , P. D. Kuzmin , A. V. Jojua , D. V. Yolkin, A. A. Stolyarov |
| |
| No 17 (2014) |
Statins at the equator of decades. 40 years since the study of 4S |
Abstract
PDF (Rus)
|
|
A. V. Susekov |
| |
| No 2 (2014) |
Ways to overcome resistance to antihypertensive therapy in hypertensive patients: role of doxazosin |
Abstract
PDF (Rus)
|
|
I. V. Emelyanov, A. O. Conradi |
| |
| No 17 (2014) |
Clinical pharmacology of angiotensin II receptor blockers: valsartan |
Abstract
PDF (Rus)
|
|
M. V. Leonova |
| |
| No 2 (2014) |
Correction of hyperuricemia in metabolic syndrome |
Abstract
PDF (Rus)
|
|
S. V. Nedogoda, A. S. Salasyuk, I. N. Barykina, A. A. Ledyaeva, V. V. Tsoma, E. V. Chumachek, V. Y. Khripaeva |
| |
| No 2 (2014) |
Metabolic syndrome and correction methods in pregnancy |
Abstract
PDF (Rus)
|
|
R. I. Stryuk, V. A. Smirnova |
| |
| 1 - 100 of 123 Items |
1 2 > >>
|
